Psychological performance tests have been used since the mid-1960s in occupational and environmental health toxicology. The interpretation of significantly diVerent test scores in neurobehavioural studies is not straightforward in the regulation of chemicals. This paper sets out some issues which emerged from discussions at an international workshop, organised by the United Kingdom Health and Safety Executive (HSE), to discuss diVerences in interpretation of human neurobehavioural test data in regulatory risk assessments. The diYculties encountered by regulators confronted with neurobehavioural studies seem to be twofold; some studies lack scientific rigor; other studies, although scientifically sound, are problematic because it is not clear what interpretation to place on the results. Issues relating to each of these points are discussed. Next, scenarios within which to consider the outcomes of neurobehavioural studies are presented. Finally, conclusions and recommendations for further work are put forward.
Psychological performance tests have been used since the mid-1960s in occupational and environmental health toxicology. 1 Within this context they are usually referred to as neurobehavioural (or neuropsychological) tests. Such tests have been used to investigate whether eVects on the nervous system occur after acute 2 or long term 3 occupational exposures to substances, typically metals-including lead, 4 manganese, 5 mercury, 6 and aluminium 7 -solvents-such as styrene, tetrachloroethylene, toluene, methyl ethyl ketone, trichloroethane, trichloroethylene, white spirit, and xylene 8 -and pesticides-organophosphates, 9 and carbamates. 10 Neurobehavioural tests measure eVects on the nervous system through simple tasks of motor speed and coordination, as well as through more complex memory and attention tasks. 11 In a typical study, several neurobehavioural tests are given at one time, to a group of people, as a test battery. 12 The generally accepted definition of a neurobehavioural eVect is that there is a significant diVerence in the score on a neurobehavioural test of a group before and after exposure, between exposed and control groups, or between groups exposed at diVerent levels.
There exists an extensive international framework of chemical regulation designed to prevent or minimise eVects of exposure on human health. Although there is considerable conformity on some ill health eVects wherefor example, when the Organisation for Economic Co-operation and Development (OECD) test methods 13 and the European Union criteria for classification for hazard 14 are used-for neurobehavioural eVects wide divergence persists in interpretation. For instance, many more patients are reported to have been diagnosed as having toxic encephalopathy (the diagnostic criteria for which require neuropsychological test deficits) in Denmark compared with other industrialised European countries. 15 Problems with the interpretation of results from neurobehavioural studies are exemplified by the case of neurobehavioural studies on 1,1,1-trichloroethane, reported in the published review Environmental Health Criteria (EHC) 136. 16 The critical eVect in humans is central nervous system depression. Several neurobehavioural volunteer studies were available. The task group concluded that the no eVect level from several of these studies seems to be in the region of 250 ppm (parts per million). It was noted that one study suggested eVects at a lower level (175 ppm) but "the interpretation of the results was unclear." This particular study reported slowed reaction time but improved attention and concentration (and no change across other test outcomes). 17 It seems that the task group for the EHC was unable to reach a firm consensus on this study. By contrast with some regulatory scientists elsewhere, technical advisers in the Health and Safety Executive (HSE) regard the no adverse eVect level to be 250 ppm and do not attach any weight to the results at 175 ppm in occupational regulatory activity on 1,1,1-trichloroethane.
The HSE held an international workshop to discuss diVerences in interpretation of human neurobehavioural test data in regulatory risk assessments. Participants included both regulatory toxicologists and neurobehavioural toxicology researchers. This paper sets out some issues which emerged from discussions at the workshop, with the aims of both encouraging debate in neurobehavioural toxicology, and of promoting some aspects relating to good practice, so that neurobehavioural toxicology studies may better be incorporated into the regulatory risk assessment process.
PROCESS OF ASSESSMENT
The diYculties encountered by regulators confronted with neurobehavioural studies seem to be twofold. Some studies lack scientific rigor; put more precisely, they contain threats to internal and external validity. 18 Other studies, although scientifically sound, are problematic because it is not clear what the implications of their reported eVects are. This suggests that a two step strategy is appropriate for evaluating neurobehavioural studies in the context of regulation; such an approach was advocated by a similar initiative recently concluded in Germany. This involves a process of first assessing study methods, to determine whether an eVect has been rigorously shown to be related to a specific exposure with epidemiological and other scientific criteria. Only after this is the second step considered of interpreting the meaning of that eVect with respect to regulation. Issues raised at the workshop are discussed within this two step strategy in this paper.
First step: has a neurobehavioural eVect been shown? STUDY 
DESIGN
The following points may be useful to those designing and evaluating studies.
Selection bias
Predetermined criteria for selection of a study group should be applied during recruitment of exposed and control groups; response and drop out rates can indicate potential bias, and should be reported.
Separation of acute and chronic eVects
In studies of possible chronic eVects, it should be clear that an interval, suYcient to allow any acute exposure eVects to subside, has elapsed between the most recent exposure and testing.
If such an interval is not allowed, then a false positive chronic eVect may result, which is, in fact, an acute exposure eVect.
Confounding or modifying factors
The table provides a list of a large range of factors that can influence human performance. As a minimum, studies should control for eVects of age, sex, educational level, and socioeconomic level. This may be achieved through matching of the control group (possibly excluding potential participants with low frequency characteristics). Statistical procedures are often used to adjust for the influence of possible additional confounders or modifiers. Repeated measures designs have the advantage of restricting covariance by making each participant their own control, although practice eVects may add confusion. Practice eVects may be controlled with counter balanced study designs, careful selection of tests more resistant to practice eVects, or training of participants to an optimal level of performance before baseline testing. Ambient conditions, such as temperature and background noise, should be kept constant as far as possible. Although, historically, studies have attempted to control for premorbid ability with tests of so called "hold" abilities-such as vocabulary tests-this procedure has been questioned recently. 19 Tester reliability For studies that use non-automated tests, measures to control reliability within and between testers-such as blinding-should be incorporated and reported.
Exposure data
Regulatory toxicology relies on determining exposure levels at which eVects do and do not occur. Hence it is imperative that positive neurobehavioural studies define clear doseresponse relations. The (often poor) quality of exposure data was a major criticism of neurobehavioural studies at the workshop. LITERATURE REVIEWS When assessing a series of studies, the Bradford-Hill 20 or similar criteria should be applied to determine causality. We discussed several of these criteria with particular reference to neurobehavioural studies.
Consistency and specificity
Replication of an observed eVect across diVerent studies conducted by diVerent investigators makes for a powerful argument that the eVect is genuine. The trend in all the studies that have been conducted is one consideration in reaching a conclusion about the eVect being real. An unresolved issue in neurobehavioural toxicology, however, is whether replication should be sought simply at test level, or at the level of the function which tests measure. Test level replication would look for similar decrements in performance on the same test across studies. Alternatively, diVerent studies might use diVerent tests which measure a common function, 26 have adopted a diVerent approach based on cognitive psychology theory. Derived from research into normal intellectual functioning, these focus more on the psychological functions which underlie performance of a test. However, these batteries are currently less widely used than the standardised batteries.
Coherence
The requirement for coherence across different types of data (biochemical, animal, and human) emerged as being a main criterion required for human neurobehavioural data to be incorporated into regulatory decision making in the United Kingdom. Some researchers argued that they would place less emphasis on this criterion if an acceptable level of consistency or specificity of the eVect of a substance had been shown.
Mechanistic plausibility
It may be argued that the existing base of neurobehavioural studies is not large enough, currently, to facilitate suYcient understanding of biologically plausible underlying mechanisms. 27 Thus some researchers argued that they would be prepared to accept a repeatedly demonstrable neurobehavioural eVect in the absence of such a mechanism.
Overall, studies should be individually scrutinised for the quality of study design and reporting, and conclusions about whether there is evidence for an exposure-related response should be drawn from consideration of all the available studies, attaching more weight to those of better quality. It might be possible to conclude that the substance causes a significant neurobehavioural eVect at a particular exposure concentration. The potential consequence of that eVect must then be considered.
Step two-interpretation of neurobehavioural eVects in the regulation of chemicals
ASSESSING THE NATURE AND SEVERITY OF NEUROBEHAVIOURAL EFFECTS
As already discussed, part of the problem faced when assessing the nature of neurobehavioural eVects arises out of the lack of understanding of the functions that neurobehavioural tests measure, and therefore, what changes in those functions mean. This can be rectified by adopting a more theoretical psychological approach, which, as already noted, some newer test batteries have done. Applying contexts to neurobehavioural eVects, through bench marking or calibrating techniques, can also facilitate understanding of their nature and severity. Such techniques involve comparing the eVects of an occupational exposure with the eVects of a reference substance or condition-such as alcohol or aging-the eVects of which are better known to those receiving the study. In this way, both the nature and the severity are illustrated by analogy. One problem associated with this approach is that the specificity of eVects of an exposure may be similar in some ways, but diVerent in others to those of the comparison agent. DiYculties also arise-for example, in alcohol intoxication-translating the kinds of chronic eVects found in epidemiological studies into acute eVects of a reference substance. A further consideration is that errors in outcome measurements or exposure classification often occur in epidemiological studies, 28 and these may introduce null bias. Null bias increases the probability of false negative studies, and attenuates significant findings, 29 hence decreasing study sensitivity. The possibility that measured neurobehavioural eVects are underestimates of true eVects, owing to null bias, should also be considered when assessing the severity of neurobehavioural eVects found in epidemiological studies.
DEFINING CRITERIA FOR ADVERSE EFFECTS
As well as appreciating the nature and severity of a neurobehavioural eVect, its likely consequences, in terms of present and future risk from perspectives of health, safety, or other factors, need to be considered when deciding if it should be treated as adverse.
When eVects are transitory-such as acute eVects found in volunteer exposure studiesthen immediate consequences, including safety or fitness to work issues, are one context in which a regulatory decision could be made. A second consideration might be whether such eVects are viewed as health eVects. Transitory eVects might also have an economic or public safety consequence. For instance, the economic consequence of the risk from sick building syndrome may be very large due to the large exposed population (potentially, all oYce workers). Also the public health consequence of an operator's failure to maintain vigilance in a situation where safety is critical-such as in a nuclear reactor control room-might be large enough for the transitory eVect to be deemed adverse.
Prevalent in the neurobehavioural literature are studies reporting subclinical neurobehavioural eVects of chronic (low level) exposure. By definition these eVects may not be perceptible to study participants. Indeed, such exposure eVects may be smaller than similar eVects of established performance modifying factors-for example, age, sex, educational level, diurnal rhythms, suYciency of sleep, and the eVects of alcohol and drugs. Regulators questioned how such eVects, likely to be imperceptible to a person, and in any case within the range of background variability in the population, can be considered adverse. Several arguments as to how such eVects might be considered to be adverse were advanced.
One argument was that as neurobehavioural tests are complex tertiary measures, with no understood mechanism, any change in the direction of poorer performance should be assumed to be adverse, until there is evidence to the contrary. However, few would agree that neurobehavioural eVects should, almost by definition, be considered to be adverse, as this argument requires. Neither does this occur in practice, as there are data indicating eVects on colour discrimination with exposure to 11 ppm styrene, 30 but no countries regulate styrene to that level. A second argument was that although the consequences of a significant, although relatively small, eVect would be imperceptible to most people, eVects would be perceptible to those whose scores fall in the tails of the distributions of population scores and therefore could be considered to be adverse.
A third argument was that a relatively small downward shift in a variable-such as inteligence quotient (IQ)-could have an economic impact if the exposed population is very large. For example, the regulatory decision to remove lead from petrol in the United States was based on data showing an inverse relation between intelligence test scores and lead exposure, in groups of children, because of the economic implications to the country as a whole of a mass downward shifting in IQ. This was despite the groups studied scoring above average on the test used. 31 A fourth argument was that, with continued exposure, currently imperceptible but measurable deficits will gradually become perceptible as health eVects. The notion of subclinical neurobehavioural decrements providing early warning is much cited in the neurobehavioural literature. 11 32 However, there exists little or no evidence in support of such a continuum between subclinical neurobehavioural eVects and clinical disease.
Conclusions
This article has outlined scenarios in which neurobehavioural eVects might be considered to be adverse. No specific criteria are oVered here to define what is adverse. This is because it is our opinion that the studies being conducted, and the tests being used, are currently too diverse to be able to set such criteria. Rather, neurobehavioural data will need to be considered on a case by case basis to determine whether regulatory action should be taken for particular substances. However, the workshop has emphasised the need for researchers to tailor neurobehavioural studies, both in design (particularly improving exposure data) and reporting, to the requirements of regulatory toxicology. By the same token, increased knowledge of psychology testing would assist those involved in the process of interpretation of neurobehavioural data for the regulation of chemicals. Some areas for research are suggested. The standardisation eVort in neurobehavioural studies may require review, as the tests currently promoted have limitations. One limitation of the standard tests is that the mental functions which underlie them are often poorly understood, and decrements may be referred to in publications by misleading terms such as "visual intelligence" or "logical memory", despite there being no evidence that such mental functions exist. 8 Newer tests specifically developed to measure functions defined by contemporary psychology research-for example, "working memory"-may yield more interpretable results, as they measure functions for which there is a knowledge base. This knowledge would be useful to regulators in determining the potential consequences of deficits in such functions. Existing data need not go to waste; bench marking the eVects measured by well established tests would improve their interpretability, as would investigating further their underlying functions. The area of subclinical neurobehavioural eVects would also benefit from further research, particularly examining whether there is a link with any future health eVects. Although the best method of researching this question would be to conduct prospective studies, a quicker answer might be provided by the approach used by Echeverria et al, 33 in which the results of neurobehavioural tests conducted with asymptomatic occupational groups are compared with results on the same tests in patients with suspected exposure related clinical nervous system disease.
In the meantime, regulatory activity continues against a background of insuYcient information about clinical outcomes. To some extent, however, the same applies to the interpretation of certain physiological variables, such as lung function, in which a deficit occurs in the absence of clinical illness. The HSE is therefore looking at parallels that can be drawn between neurobehavioural and physiological test models. The changing public perception of the concept of health, from a simple disease free concept, to quality of life issues could lead to more rigorous debate about the significance of eVects such as those found in neurobehavioural studies. This paper follows on from the discussions recorded at a workshop sponsored by the Health and Safety Executive on 8-9 February 1996.
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